Pioneering RNA Cell Therapy for
autoimmune diseases and cancer
Pioneering RNA Cell Therapy for autoimmune diseases and cancer
Our Commitment to our Patients
We are committed to developing potent yet safer cell therapies for patients with autoimmune diseases and cancer.
Our therapeutic candidates
We are conducting clinical trials in patients with myasthenia gravis and multiple myeloma.
We are an integrated team of physicians and scientists working to develop the safest, most effective RNA cell therapies for our patients.
Stay up to date on Cartesian
Cartesian Therapeutics Strengthens Research and Innovation Leadership with appointment of Professor Christopher M. Jewell as Chief Scientific Officer
Gaithersburg, MD—February 14, 2023 – Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases and cancer, today announced the appointment…